Context Therapeutics(CNTX)
$0.18-0.02 (-9.09%)
CNTX
Context Therapeutics earnings date
$0.18
At close:-0.02 (-9.09%)
Want to see CNTX full AI Analyst Report?
Context Therapeutics (CNTX) Q2 2022 Earnings Report
328 Followers
CNTX Q2 2022 EPS Results
- Actual EPS
- -$0.25
- Consensus EPS
- -$0.25
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -$0.46
CNTX Q2 2022 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/11/2022
- Time
- After Close
- Conference Call
- Thursday, August 11, 2022
CNTX Upcoming Earnings
Context Therapeutics's next earnings date is estimated for March 24, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
CNTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 24, 2027 | 2026 (Q4) | -0.10- | -0.14 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.11-0.08 | -0.1 | 20.00% (+0.02) | |
| Aug 05, 2026 | 2026 (Q2) | -0.09-0.15 | -0.09 | -66.67% (-0.06) | |
| May 06, 2026 | 2026 (Q1) | -0.11-0.09 | -0.05 | -80.00% (-0.04) | |
| Mar 23, 2026 | 2025 (Q4) | -0.10-0.14 | -0.03 | -366.67% (-0.11) | |
| Nov 05, 2025 | 2025 (Q3) | -0.09-0.10 | -0.22 | 54.55% (+0.12) | |
| Aug 06, 2025 | 2025 (Q2) | -0.05-0.09 | -0.04 | -125.00% (-0.05) | |
| May 07, 2025 | 2025 (Q1) | -0.06-0.05 | -0.23 | 78.26% (+0.18) | |
| Mar 20, 2025 | 2024 (Q4) | -0.09-0.03 | -0.42 | 92.86% (+0.39) | |
| Nov 06, 2024 | 2024 (Q3) | -0.09-0.22 | -0.37 | 40.54% (+0.15) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
